In a recent preprint* uploaded to the bioRxiv server, researchers in the United States developed and tested a novel mucosal-administered adenoviral-vector vaccine christened "ChAd-SARS-CoV-2-S" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results